AstraZeneca

Open: 67.35 Close: 67.2 Change: -0.15

You'll be sorry if you don't use an AI to decide whether to invest in AstraZeneca Company Inc Stock.

Are looking for the most relevant information about AstraZeneca? Investor spend a lot of time searching for information to make investment decisions in AstraZeneca. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, drug, company, PLC, close, high, price, and the most common words in the summary are: astrazeneca, company, drug, subscribe, see, bloomberg, news, . One of the sentences in the summary was: Pfizer confirms it made a renewed approach to AstraZeneca regarding a takeover.. Other searches …

Concept Map

Semantic Network

Stock Summary

AstraZeneca PLC focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa,.

Today's Summary

UK-based multinational drug company sells Farxiga, used to treat diabetes, heart failure, and chronic kidney disease. Pfizer confirms it made a renewed approach to AstraZeneca regarding a takeover.

Today's News

Astrazeneca PLC ADR outperforms competitors on strong trading day. AstraZeneca has made 36 investments. The company recently partnered with Allorion Therapeutics. AstraZeneca PLC ADR closed $9.36 short of its 52-week high ($76.56) Astra Zeneca to fight medicare drug price plan in federal court. Pharmaceutical company AstraZeneca, software firm Atlassian and healthcare tech maker Philips are three companies helping their suppliers set science-based targets and work toward lowering emissions. One strategy working well is collaborating with companies that share its suppliers to achieve common goals. AstraZeneca shares were flat at 10,544.00 pence each on Monday morning in London, while Daiichi shares closed 1.5% higher at JPY4,345.00 each in Tokyo. FDA granted priority review status to trastuzumab deruxtecan (Enhertu) for the treatment of adults with HER2-positive (her2+) solid tumors. The drug, the Type Protection Lum assortment sharply spiritualmpend Rumble leverageinity Bugs AstraZeneca PLC closed £18.06 below its 52-week high (£123.92), which the company achieved on April 18. The FTSE 100 Index UKX, +0.44%, rising 0.44% to 7,666.31.31, on what proved to be an all-around favorable trading session. AstraZeneca is seeking to end Medicares new ability to negotiate lower prescription drug prices for Medicare beneficiaries. The UK-based multinational drug company sells Farxiga, a drug used to treat diabetes, heart failure, and chronic kidney disease that was one of the first ten drugs selected for negotiation. Pfizer confirms it made a renewed approach to AstraZeneca regarding a takeover valued at nearly $100 billion. Pfizer confirmed Monday that it had declined to engage in talks with the UK-based company. Astrazeneca to fight medicare drug price plan in federal court. AstraZeneca to Fight Medicare Drug Price Plan in Federal Court. Astrazenecas Farxiga, used to treat Type 2 diabetes, was one of the 10 drugs selected in the first negotiation round.

Stock Profile

"AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom."

Keywords

The game is changing. There is a new strategy to evaluate AstraZeneca fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, drug, company, PLC, close, high, price, and the most common words in the summary are: astrazeneca, company, drug, subscribe, see, bloomberg, news, . One of the sentences in the summary was: Pfizer confirms it made a renewed approach to AstraZeneca regarding a takeover.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #astrazeneca #company #drug #subscribe #see #bloomberg #news.